Opko Health (OPK) Invested Capital (2010 - 2026)

Opko Health (OPK) has 17 years of Invested Capital data on file, last reported at $10.6 million in Q2 2026.

• Quarterly Invested Capital fell 24.71% year-over-year to $10.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $43.2 million (down 20.28% YoY) and the FY2025 annual result came in at $10.3 million, down 30.97% from the prior year.
• Invested Capital rose to $10.6 million in Q2 2026, from $9.6 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $33.5 million in Q4 2022 to a low of $9.6 million in Q1 2026.
• A 5-year average of $19.2 million and a median of $18.2 million in 2022 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 128.24% — and 2024, when it plunged 56.1%.
• Tracing OPK's Invested Capital over 5 years: stood at $33.5 million in 2022, then declined by 18.63% to $27.3 million in 2023, then sank by 45.59% to $14.8 million in 2024, then slumped by 30.97% to $10.3 million in 2025, then gained by 2.99% to $10.6 million in 2026.
• The last three Invested Capital figures came in at $10.6 million (Q2 2026), $9.6 million (Q1 2026), and $10.3 million (Q4 2025), per Business Quant data.